Reply #19: numbers and blather at 1:21 EST

[UpInArms]

Dow 10,281.99 +86.08 (+0.84%)
Nasdaq 1,992.17 +31.91 (+1.63%)
S&P 500 1,127.28 +10.64 (+0.95%)
10-Yr Bond 4.748% +0.036

1:00PM: After trading in the same range for most of the session, stocks break out, aided by a breach of the major averages' early week/recovery highs... Just about every sector has found buyers and marched even higher - with the exception of oil service (although it has moved off its lows)... The indices' ability to retain most of their gains in the early trade, although with their move through several key resistance points, have invited more buying interest in the afternoon...

As it stands now, the Dow, Nasdaq, and S&P 500 are poised to close higher for the week - marking their second consecutive week of gains...NYSE Adv/Dec 2289/839, Nasdaq Adv/ Dec 2100/884

12:30PM: Indices work their way higher, breaching their best levels set early in the session... Market internals remain positive and supportive of the buying drive... Presently, 26 of the Dow's 30 components are showing gains and keeping the blue chip average implanted in positive territory... One of the 4 issues to buck the trend is Johnson & Johnson (JNJ 56.50 - 0.09)... The drug company's rival in the drug-eluting stent race - Boston Scientific (BSX 43.12 -0.58) - reported preliminary May US sales of $157 mln...

The company's Taxus stent continues to claim over 70% of the US market, leaving Johnson & Johnson's Cypher with a smaller chunk of the pie... NYSE Adv/Dec 2090/982, Nasdaq Adv/Dec 1990/950

just a quick pop-in and post :D